{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:48:50Z","timestamp":1784544530873,"version":"3.55.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ekir.2025.01.040","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T16:22:32Z","timestamp":1738426952000},"page":"1296-1299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Topical Timolol in the Treatment of Hemodialysis Tunneled Catheter Exit-Site Pyogenic Granuloma"],"prefix":"10.1016","volume":"10","author":[{"given":"Renato A.","family":"Caires","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A.S.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Arakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlucci G.","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Di Nizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Carlo R.","family":"Pegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicio L.","family":"Roque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Jos\u00e9 Mauro","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio","family":"Luders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2025.01.040_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.6538","article-title":"Oral propranolol and topical timolol in the treatment of post-burn pyogenic granuloma: two cases and review of literature","volume":"10","author":"Ebrahimi","year":"2022","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.ekir.2025.01.040_bib2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jpeds.2015.10.047","article-title":"Noninvasive treatment of pyogenic granulomas in young children topical timolol and tricholoroacetic acid","volume":"169","author":"Chiriac","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ekir.2025.01.040_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/pde.12217","article-title":"Treatment of pediatric pyogenic granulomas using \u03b2-adrenergic receptor antagonists","volume":"31","author":"Lee","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ekir.2025.01.040_bib4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.25259\/IJDVL_565_20","article-title":"Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: a randomized, double-blind and placebo-controlled study","volume":"88","author":"Patra","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.ekir.2025.01.040_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15016","article-title":"Topical beta-blockers in dermatologic therapy","volume":"34","author":"Filoni","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ekir.2025.01.040_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jdin.2022.03.014","article-title":"Topical treatment of pyogenic granulomas in a pediatric population: a single-institution retrospective review","volume":"7","author":"Barry","year":"2022","journal-title":"JAAD Int"},{"key":"10.1016\/j.ekir.2025.01.040_bib7","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.ekir.2025.01.040_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/ced.15021","article-title":"Topical timolol in dermatology: infantile hemangiomas and beyond","volume":"47","author":"Alzaid","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ekir.2025.01.040_bib9","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1111\/pde.13575","article-title":"Topical timolol: an effective option for agminated pyogenic granuloma","volume":"35","author":"McGinness","year":"2018","journal-title":"Pediatr Dermatol"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024925000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024925000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:00:56Z","timestamp":1747285256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024925000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2468024925000658"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2025.01.040","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Timolol in the Treatment of Hemodialysis Tunneled Catheter Exit-Site Pyogenic Granuloma","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2025.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}